- 理想的成長型公司, 本業EPS的成長幅度會大於營收的成長幅度
- 營收到某個數字後, 本業EPS呈現不成比例的增加, 有可能是規模經濟的效應
- 如果是有淡旺季的公司, 是否有淡季不淡, 旺季更旺的情況
- 漲很多的股票要留意 EPS 較上季是否有大幅衰退的情況
- 如果EPS衰退，要觀察同業是不是有一樣的狀況
- 要留意增資減資和公司債對股本及EPS的影響
| 加權平均股數 QoQ YoY | EPS QoQ YoY | 本業EPS QoQ YoY | 累計EPS QoQ YoY | 營收 QoQ YoY | 毛利率(%) QoQ YoY | 營業利益率 QoQ YoY | 稅後淨利率 QoQ YoY | 營業利益 QoQ YoY | 稅後淨利 QoQ YoY | 稅前淨利率(%) QoQ YoY | 稅後淨利率(%) QoQ YoY | 兩季平均(YOY)營收成長率(%) | 兩季平均(YOY)EPS成長率(%) | 兩季平均(YOY)本業EPS成長率(%) | |||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 24Q1 (20) | 55 | 19.57 | 25.0 | -1.56 | 26.76 | -16.42 | -1.60 | 14.44 | -46.79 | -1.56 | 81.9 | -16.42 | 0.05 | 66.67 | 0.0 | -61.45 | 43.06 | -68.26 | -1777.60 | 41.29 | -49.07 | -1721.54 | 40.65 | -45.72 | -0.89 | 14.42 | -48.33 | -0.85 | 14.14 | -44.07 | -1721.54 | 40.65 | -45.72 | -1721.54 | 40.65 | -45.72 | 13.34 | 23.04 | 14.33 |
| 23Q4 (19) | 46 | 2.22 | 17.95 | -2.13 | 19.32 | -37.42 | -1.87 | 14.22 | -65.49 | -8.62 | -28.08 | -46.85 | 0.03 | -40.0 | -50.0 | -107.93 | 53.71 | -187.58 | -3027.64 | -14.33 | -179.51 | -2900.44 | -11.05 | -173.08 | -1.04 | 14.05 | -65.08 | -0.99 | 16.1 | -62.3 | -2900.44 | -11.05 | -173.08 | -2900.44 | -11.05 | -173.08 | -20.00 | 11.84 | 9.51 |
| 23Q3 (18) | 45 | 2.27 | 2.27 | -2.64 | 4.35 | -72.55 | -2.18 | 4.8 | -75.81 | -6.73 | -64.55 | -74.81 | 0.05 | 0.0 | 25.0 | -233.14 | -16.64 | -202.03 | -2648.21 | -4.37 | -55.15 | -2611.72 | -5.8 | -55.72 | -1.21 | 4.72 | -75.36 | -1.18 | 4.07 | -76.12 | -2611.72 | -5.8 | -55.72 | -2611.72 | -5.8 | -55.72 | 0.00 | -50.81 | -52.65 |
| 23Q2 (17) | 44 | 0.0 | 0.0 | -2.76 | -105.97 | -17.95 | -2.29 | -110.09 | -21.16 | -4.09 | -205.22 | -74.79 | 0.05 | 0.0 | -28.57 | -199.88 | -447.32 | -145.58 | -2537.45 | -112.8 | -78.04 | -2468.64 | -108.96 | -77.31 | -1.27 | -111.67 | -20.95 | -1.23 | -108.47 | -20.59 | -2468.60 | -108.96 | -77.31 | -2468.64 | -108.96 | -77.31 | -8.34 | -46.21 | -53.27 |
| 23Q1 (16) | 44 | 12.82 | 0 | -1.34 | 13.55 | 0 | -1.09 | 3.54 | 0 | -1.34 | 77.17 | 0 | 0.05 | -16.67 | 0 | -36.52 | 2.69 | 0 | -1192.42 | -10.09 | 0 | -1181.37 | -11.23 | 0 | -0.6 | 4.76 | 0 | -0.59 | 3.28 | 0 | -1181.37 | -11.23 | 0 | -1181.37 | -11.23 | 0 | 16.66 | 6.12 | 6.21 |
| 22Q4 (15) | 39 | -11.36 | 0 | -1.55 | -1.31 | 0 | -1.13 | 8.87 | 0 | -5.87 | -52.47 | -3.71 | 0.06 | 50.0 | 0 | -37.53 | 51.38 | 0 | -1083.18 | 36.54 | 0 | -1062.11 | 36.67 | 0 | -0.63 | 8.7 | 0 | -0.61 | 8.96 | 0 | -1062.11 | 36.67 | 0 | -1062.11 | 36.67 | 0 | 3.57 | 16.65 | 21.63 |
| 22Q3 (14) | 44 | 0.0 | 0 | -1.53 | 34.62 | 0 | -1.24 | 34.39 | 0 | -3.85 | -64.53 | 0 | 0.04 | -42.86 | 0 | -77.19 | 5.16 | 0 | -1706.84 | -19.76 | 0 | -1677.19 | -20.46 | 0 | -0.69 | 34.29 | 0 | -0.67 | 34.31 | 0 | -1677.19 | -20.46 | 0 | -1677.19 | -20.46 | 0 | -21.43 | 17.31 | 17.20 |
| 22Q2 (13) | 44 | 0 | 0 | -2.34 | 0 | 0 | -1.89 | 0 | 0 | -2.34 | 0 | 0 | 0.07 | 0 | 0 | -81.39 | 0 | 0 | -1425.25 | 0 | 0 | -1392.27 | 0 | 0 | -1.05 | 0 | 0 | -1.02 | 0 | 0 | -1392.27 | 0 | 0 | -1392.27 | 0 | 0 | 0.00 | 0.00 | 0.00 |
| 年/月 | 營收 | 月增率(%) | 去年同期年增率(%) | 累計營收 | 累計營收年增率(%) | 近三月累計營收 | 存貨銷售比 | 自結稅前EPS | 自結稅前累計EPS | 備註(年增率變動50%需說明原因) |
|---|---|---|---|---|---|---|---|---|---|---|
| 2024/6 | 0.01 | -5.48 | -42.13 | 0.1 | -0.43 | 0.05 | N/A | - | ||
| 2024/5 | 0.01 | -32.95 | 4.66 | 0.09 | 12.5 | 0.05 | N/A | - | ||
| 2024/4 | 0.02 | 19.95 | 79.24 | 0.07 | 14.25 | 0.06 | N/A | 本期拓展新的合作醫療院所及目前合作的醫療院所增加「細胞治療」營業收入，故較去年同期增加超過50% | ||
| 2024/3 | 0.02 | 10.0 | -10.37 | 0.05 | -1.32 | 0.0 | N/A | - | ||
| 2024/2 | 0.02 | 7.35 | 19.06 | 0.03 | 4.7 | 0.0 | N/A | - | ||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A | |||
| N/A | N/A | N/A | N/A | N/A | N/A | 0 | N/A |
| 加權平均股數 YoY | EPS YoY | 本業EPS YoY | 營收 YoY | 毛利率(%) YoY | 營業利益率 YoY | 稅後淨利率 YoY | 營業利益 YoY | 稅前淨利 YoY | 稅後淨利 YoY | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023 (10) | 46 | 17.95 | -8.62 | 0 | -7.44 | 0 | 0.18 | 5.88 | -144.96 | 0 | -2280.52 | 0 | -2225.03 | 0 | -4.11 | 0 | -4.01 | 0 | -3.99 | 0 |
| 2022 (9) | 39 | 18.18 | -5.87 | 0 | -4.27 | 0 | 0.17 | 21.43 | -65.61 | 0 | -1376.17 | 0 | -1347.99 | 0 | -2.36 | 0 | -2.31 | 0 | -2.3 | 0 |
| 2021 (8) | 33 | 0 | 0.00 | 0 | -3.56 | 0 | 0.14 | 0 | -31.27 | 0 | -1402.03 | 0 | -1351.93 | 0 | -1.96 | 0 | -1.89 | 0 | -1.89 | 0 |
